Clinical Trials Directory

Trials / Conditions / Skin Diseases, Bacterial

Skin Diseases, Bacterial

17 registered clinical trials studyying Skin Diseases, Bacterial — 1 currently recruiting.

StatusTrialSponsorPhase
CompletedDalbavancin in Real Clinical Practice in Spain
NCT04485676
Angelini Farmacéutica—
CompletedContezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
NCT03747497
MicuRxPhase 2
CompletedSafety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and S
NCT02925416
The Medicines CompanyPhase 4
RecruitingFosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951
Infectopharm Arzneimittel GmbH—
CompletedA Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Ros
NCT02477514
Merck Sharp & Dohme LLCPhase 1
CompletedStudy of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-0
NCT02276482
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Phase 3
TerminatedAsymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections
NCT01619410
University of ChicagoN/A
UnknownSimple Hygiene Versus Alcohol Based Usual Care for Umbilical Cord
NCT01369251
ASST Fatebenefratelli SaccoPhase 3
CompletedSafety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections
NCT00948142
Arrevus Inc.Phase 2
CompletedPhase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
NCT00761215
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Phase 2
CompletedStudy Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years
NCT00488345
Wyeth is now a wholly owned subsidiary of PfizerPhase 2
CompletedStudy Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to
NCT00368537
Wyeth is now a wholly owned subsidiary of PfizerPhase 4
CompletedStudy of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI
NCT00303550
Arpida AGPhase 3
CompletedAvelox in Complicated Skin and Skin Structure Infections
NCT00997997
Bayer—
CompletedCeftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
NCT00210899
Basilea PharmaceuticaPhase 3
CompletedCeftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
NCT00228982
Basilea PharmaceuticaPhase 3
CompletedA Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed
NCT00249197
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3